ETERN has Developed Novel Protein
LLPS Technology Platform to Drug "Undruggable" Targets
- Transcriptional Factors
- Protein-Protein Interaction
- Ras, etc.
Why Target “Undruggable” ?
Strong Disease Link
Based on Deep Understanding of STRUCTURE DYNAMICS, We Combine Strong Expertise on Hit Generation, Structural Biology, CADD and MedChem to Target Undruggable Proteins and Deliver Novel Drug Candidates
Liquid-Liquid Phase Separation (LLPS):
- Biomolecular condensates, an emerging paradigm of cellular organization
- Involved in various critical biological functions
- Implicated in many human diseases such as neurodegenerative diseases and cancers
Many “undruggable” targets undergo LLPS to activate their biological functions
LLPS of “undruggable” targets can be regulated by small molecule inhibitors
Through integrated screening approaches, we have been successful in identifying small molecules regulating protein LLPS